Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study is an open label, two armed trial evaluating the safety and efficacy of Fenfuro
capsule twice daily for 90 days in 100 patients with type 2 diabetes that will be conducted
in single center in India. The primary outcome measures will be the determination of decrease
in plasma glucose levels from baseline to last visit. The secondary outcome will be the
determination of safety of Fenfuro capsule in type 2 diabetic subjects.